-
Three emerging-market stocks to diversify your portfolio
Opinion Omar Negyal, portfolio manager, JPMorgan Global Emerging Markets Income Trust, highlights three emerging-market stocks where he’d put his money
Opinion -
Coface offers excess profit in an unloved sector
Coface is a world leader in trade-credit insurance with key competitive advantages in a niche market
-
Profit from pest control with Rentokil Initial
Rentokil Initial is set for global expansion and offers strong sales growth
-
Tap income and capital growth in markets worldwide
Opinion Three investment trusts with potential for capital growth, selected by Adam Norris, co-portfolio manager of the CT Global Managed Portfolio Trust
Opinion -
PayPoint: A promising stock for income-seekers
PayPoint, a household name across Britain, is moving away from its traditional roots toward a digital future. Investors after a steady income should buy in
-
Three Indian stocks to buy for long-term profit growth
Opinion Rita Tahilramani and James Thom, co-managers at the Aberdeen New India Investment Trust, highlight three Indian stocks to buy now
Opinion -
Vaccines inject billions into Big Pharma – how to profit
The vaccines subsector received a big fillip from Covid, but its potential extends far beyond combating pandemics. Here's what it means for investors
-
Where to invest – MoneyWeek writers give their tips for 2026
MoneyWeek's investment writers share their tips for 2026, including obesity drugs, a risky miner, central Europe and one of our favourite equity-income trusts
-
Goodwin: A superlative British manufacturer to buy now
Veteran engineering group Goodwin has created a new profit engine. But following its tremendous run, can investors still afford the shares?
